TBI (Traumatic Brain Injury)

1
Pipeline Programs
3
Companies
3
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Novo Nordisk
Novo NordiskBAGSVAERD DENMARK, Denmark
1 program
1
Growth HormonePhase 21 trial
Active Trials
NCT04121780Recruiting42Est. Sep 2026
B
BrainScopeMD - Bethesda
1 program
EEG RecordingN/A1 trial
Active Trials
NCT04279431Active Not RecruitingEst. Sep 2024
Eagle Pharmaceuticals
Eagle PharmaceuticalsNJ - Woodcliff Lake
1 program
i-STAT Alinity TBI testN/A1 trial
Active Trials
NCT07373509Recruiting340Est. Apr 2030

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Novo NordiskGrowth Hormone
Eagle Pharmaceuticalsi-STAT Alinity TBI test
BrainScopeEEG Recording

Clinical Trials (3)

Total enrollment: 382 patients across 3 trials

Growth Hormone Replacement Therapy for Retried Professional Football Players

Start: Oct 2019Est. completion: Sep 202642 patients
Phase 2Recruiting
NCT07373509Eagle Pharmaceuticalsi-STAT Alinity TBI test

Emergency Department Implementation of the i-STAT Alinity Traumatic Brain Injury Whole Blood Test

Start: Jan 2026Est. completion: Apr 2030340 patients
N/ARecruiting

Follow-up of MTBI Patients Discharged from the ED Using Standard Clinical Triage Including BrainScope One

Start: May 2020Est. completion: Sep 2024
N/AActive Not Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 actively recruiting trials targeting 382 patients
3 companies competing in this space